Articoli recenti
- Bundibugyo ebolavirus: supporting vaccine development for an emerging public health threat
- VisMederi Expands Its Service Portfolio with End-to-End Sample Kit Management
- VisMederi and CEVAC Sign Memorandum of Understanding to Strengthen Vaccine Clinical Trial Capabilities in Europe
- VisMederi and KingMylab Sign Strategic Partnership to Strengthen Global Clinical Trial Testing Services for Vaccines and Biologics
- VisMederi signs vaccine research partnership with GCCL at World Vaccine Congress 2026
Commenti recenti
No comments to show.
Archivi
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- January 2026
- December 2025
- November 2025
- October 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- February 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- June 2024
- May 2024
- April 2024
- January 2024
- November 2023
- October 2023
- August 2023
- July 2023
- May 2023
- December 2022
- November 2022
- September 2022
- June 2022
- May 2022
- March 2022
- October 2021
- August 2018
- October 2017
- May 2017
- March 2017
- November 2016
- October 2016
- September 2016
- August 2016
- January 2016
- October 2015
- July 2015
- May 2015
- January 2015
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- November 2013
- September 2013
- April 2013